RNA Live signals | Maximize Profits with Getagraph.com

BUY 93660 min ago

@ $13.56

Issued: 14 Feb 2024 @ 14:05

Return: 67.63%

Previous signal: Feb 13 - 15:50

Previous signal: Sell

Return: 1.88 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Stats
Today's Volume	998 222
Average Volume	1.19M
Market Cap	1.81B
EPS	$0 ( 2024-02-27 )
Next earnings date	( $-0.810 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.81
ATR14	$0.0580 (0.26%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-03	Levin Arthur A	Sell	20 000	Common Stock
2024-04-02	Boyce Sarah	Sell	28 000	Stock Option (Right to Buy)
2024-04-02	Boyce Sarah	Buy	28 000	Common Stock
2024-04-02	Boyce Sarah	Sell	28 000	Common Stock
2024-03-19	Levin Arthur A	Sell	5 000	Stock Option (Right to Buy)

INSIDER POWER
25.09
Last 100 transactions
Buy: 3 116 200 \| Sell: 1 613 152

Volume Correlation

Long: 0.10 (neutral)

Short: 0.85 (strong)

Signal:(64.18) Same movement expected

Avidity Biosciences Inc Correlation

10 Most Positive Correlations
RENT	0.957
RXDX	0.944
VBNK	0.942
TACO	0.933
GLRE	0.931
MOMO	0.93
ICVX	0.929
MLVF	0.929
ACAD	0.926
HAPP	0.925

10 Most Negative Correlations
PIII	-0.937
SMFL	-0.936
SPCX	-0.928
SYBT	-0.925
LUCD	-0.921
TRIT	-0.916
THFF	-0.914
UCBI	-0.913
VORB	-0.912
BCAB	-0.912

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Avidity Biosciences Inc Correlation - Currency/Commodity

0.17
( neutral )

0.14
( neutral )

0.00
( neutral )

-0.03
( neutral )

-0.11
( neutral )

-0.29
( neutral )

Avidity Biosciences Inc Financials

Annual	2023
Revenue:	$9.56M
Gross Profit:	$7.46M (78.02 %)
EPS:	$-2.91

Q4	2023
Revenue:	$2.19M
Gross Profit:	$1.58M (71.96 %)
EPS:	$-0.790

Q3	2023
Revenue:	$2.82M
Gross Profit:	$1.52M (53.87 %)
EPS:	$-0.710

Q2	2023
Revenue:	$2.32M
Gross Profit:	$1.06M (45.55 %)
EPS:	$-0.660

Financial Reports:

No articles found.

Avidity Biosciences Inc

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.